03-03-2025 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
740.06 |
-0.05 |
-0.05 |
-0.32 |
Avadel Pharmaceuticals GAAP EPS of -$0.05 misses by $0.01, revenue of $50.41M beats by $0.38M [3/3/2025 7:15 AM] |
7.54 |
-0.37 (-4.61%) |
8.00 |
0.09 (1.14%) |
7.39 - 19.09 |
1,328,579 |
1,580,000 |
7,498 |
|
|
08-01-2025 |
AH |
|
AVDL |
Avadel Pharmaceuticals plc |
1,070 |
N/A |
-0.03 |
-0.32 |
Avadel announces preliminary Q4 net product revenue of $50 million [1/8/2025 4:28 PM] |
10.69 |
-0.17 (-1.57%) |
7.95 |
-2.74 (-25.63%) |
9.41 - 19.09 |
1,418,846 |
830,000 |
880,387 |
|
|
12-11-2024 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
1,530 |
-0.03 |
-0.06 |
-0.41 |
Avadel Pharmaceuticals plc GAAP EPS of -$0.03 beats by $0.03, revenue of $50M beats by $1.37M [11/12/2024 9:35 AM] |
13.05 |
-3.25 (-19.91%) |
15.51 |
-0.79 (-4.85%) |
10.25 - 19.09 |
4,623,856 |
1,390,000 |
26,645 |
|
|
08-08-2024 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
1,600 |
-0.14 |
-0.17 |
-0.70 |
|
15.69 |
-0.42 (-2.58%) |
17.36 |
1.26 (7.83%) |
9.50 - 19.09 |
2,171,935 |
810,000 |
14,802 |
|
|
08-05-2024 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
1,690 |
-0.30 |
-0.25 |
-0.48 |
Avadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28M [5/8/2024 7:49 AM] |
16.21 |
-1.97 (-10.84%) |
16.10 |
-2.08 (-11.44%) |
9.50 - 19.09 |
4,025,661 |
800,000 |
19,019 |
|
|
04-03-2024 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
1,130 |
-0.32 |
-0.28 |
-0.44 |
Avadel Pharmaceuticals GAAP EPS of -$0.32 misses by $0.07, revenue of $19.5M misses by $6.2M [3/4/2024 6:34 AM] |
16.23 |
2.51 (18.26%) |
14.00 |
0.28 (2.04%) |
8.00 - 17.24 |
9,763,038 |
1,610,000 |
49,178 |
|
|
08-11-2023 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
959.81 |
-0.41 |
-0.35 |
-0.33 |
Avadel Pharmaceuticals GAAP EPS of -$0.41 misses by $0.04, revenue of $7.01M beats by $1.88M [11/8/2023 7:15 AM] |
11.63 |
1.25 (12.04%) |
11.50 |
1.12 (10.79%) |
5.64 - 16.85 |
2,741,003 |
480,000 |
23,389 |
|
|
09-08-2023 |
PM |
|
AVDL |
Avadel Pharmaceuticals plc |
1,030 |
-0.70 |
-0.39 |
-0.50 |
Avadel Pharmaceuticals GAAP EPS of -$0.83 misses by $0.45, revenue of $1.5M beats by $0.77M [8/9/2023 7:08 AM] |
12.84 |
-0.67 (-4.96%) |
13.40 |
-0.11 (-0.81%) |
4.61 - 16.85 |
1,589,904 |
590,000 |
47,880 |
|
|
04-05-2023 |
AH |
After the close (May 4) |
AVDL |
Avadel Pharmaceuticals |
1,034 |
-0.48 |
-0.37 |
0.00 |
Avadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10 [5/4/2023 5:19 PM] |
14.96 |
0.71 (5.02%) |
14.56 |
0.31 (2.18%) |
1.05 - 15.78 |
1,985,245 |
1,540,000 |
258 |
|
|
09-11-2022 |
PM |
7:00 AM ET (Nov 9) |
AVDL |
Avadel Pharmaceuticals |
378.00 |
-0.33 |
-0.22 |
0.00 |
Avadel Pharmaceuticals GAAP EPS of -$0.33 misses by $0.07 [11/9/2022 7:35 AM] |
5.74 |
-0.48 (-7.69%) |
6.36 |
0.14 (2.25%) |
1.05 - 11.59 |
779,934 |
450,000 |
375 |
|
|
09-08-2022 |
PM |
7:00 AM ET (Aug 9) |
AVDL |
Avadel Pharmaceuticals plc |
275.12 |
-0.50 |
-0.41 |
-0.33 |
Avadel Pharmaceuticals GAAP EPS of -$1.07 misses by $0.66 [8/9/2022 7:02 AM] |
7.26 |
0.95 (15.06%) |
6.30 |
-0.01 (-0.16%) |
1.05 - 11.59 |
1,634,857 |
670,000 |
55,951 |
|
|
17-03-2022 |
PM |
8:00 AM ET (Mar 17) |
AVDL |
Avadel Pharmaceuticals plc |
403.89 |
-0.38 |
-0.41 |
-0.24 |
Avadel Pharmaceuticals GAAP EPS of -$0.38 beats by $0.03 [3/17/2022 7:03 AM] |
7.32 |
0.29 (4.20%) |
0.0 |
0.0 (0.00%) |
4.93 - 11.59 |
940,688 |
409,773 |
0 |
|
|
08-11-2021 |
PM |
8:00 AM ET (Nov 8) |
AVDL |
Avadel Pharmaceuticals plc |
605.89 |
-0.38 |
-0.38 |
-0.20 |
Avadel Pharmaceuticals EPS beats by $0.01 [11/8/2021 8:13 AM] |
10.93 |
0.51 (4.89%) |
10.50 |
0.08 (0.77%) |
5.59 - 11.45 |
1,263,932 |
710,000 |
13,820 |
|
|
09-08-2021 |
PM |
8:00 AM ET (Aug 9) |
AVDL |
Avadel Pharmaceuticals plc |
454.45 |
-0.33 |
-0.31 |
-0.16 |
Avadel Pharmaceuticals EPS misses by $0.02 [8/9/2021 8:06 AM] |
7.81 |
-0.09 (-1.14%) |
7.89 |
-0.01 (-0.13%) |
4.83 - 10.32 |
240,276 |
280,000 |
151 |
|
|
10-05-2021 |
PM |
7:00 AM ET (May 10) |
AVDL |
Avadel Pharmaceuticals plc |
433.81 |
-0.23 |
-0.32 |
-0.02 |
Avadel Pharmaceuticals EPS beats by $0.09 [5/10/2021 8:05 AM] |
8.06 |
-0.11 (-1.35%) |
8.34 |
0.17 (2.08%) |
4.83 - 10.32 |
267,491 |
260,000 |
1,609 |
|
|
09-03-2021 |
PM |
7:00 AM ET (Mar 9) |
AVDL |
Avadel Pharmaceuticals plc |
449.87 |
-0.24 |
-0.28 |
-0.07 |
Avadel Pharmaceuticals EPS beats by $0.09 [3/9/2021 7:05 AM] |
8.03 |
0.50 (6.64%) |
7.98 |
0.45 (5.98%) |
4.00 - 13.49 |
342,665 |
549,622 |
5,755 |
|
|
09-11-2020 |
PM |
8:00 AM ET (Nov 9) |
AVDL |
Avadel Pharmaceuticals plc |
331.28 |
-0.20 |
-0.26 |
-0.24 |
Avadel Pharmaceuticals EPS beats by $0.04 [11/9/2020 7:04 AM] |
6.03 |
0.63 (11.67%) |
5.80 |
0.40 (7.41%) |
4.00 - 13.49 |
947,065 |
427,168 |
26,485 |
|
|
10-08-2020 |
PM |
7:00 AM ET (Aug 10) |
AVDL |
Avadel Pharmaceuticals plc |
492.93 |
-0.16 |
-0.18 |
-0.23 |
Avadel Pharmaceuticals EPS of $0.49 [8/10/2020 8:02 AM] |
7.85 |
-0.51 (-6.10%) |
8.79 |
0.43 (5.14%) |
1.82 - 13.49 |
536,994 |
414,418 |
3,292 |
|
|